Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

13.07.2026

1 Am Heart J
1 Am J Epidemiol
1 Am J Ophthalmol
1 BMJ
1 Circulation
1 Clin Chem
4 Diabet Med
1 Diabetes
8 Diabetes Care
24 Diabetes Obes Metab
2 Invest Ophthalmol Vis Sci
2 J Diabetes Complications
1 J Exp Med
1 J Nutr
1 PLoS Med
5 PLoS One


    Am Heart J

  1. VILLASCHI A, Pini D, Stolfo D, Baldetti L, et al
    Cardio-kidney-metabolic overlap in patients with severe heart failure: data from the HELP-HF registry.
    Am Heart J. 2026 Jun 3:107508. doi: 10.1016/j.ahj.2026.107508.
    >> Share


    Am J Epidemiol

  2. MONTGOMERY BW, Elkasabi M, Brannock MD, Marcial L, et al
    Assessing the generalizability of prevalence estimates from the All of Us Research Program.
    Am J Epidemiol. 2026;195:1962-1973.
    >> Share


    Am J Ophthalmol

  3. TRAN J, Chhablani J
    Unsuccessful Clinical Trials in Retina: Lessons Learned.
    Am J Ophthalmol. 2026;288:284-294.
    >> Share


    BMJ

  4. EVANS L
    Life with type 1 diabetes is much more than numbers.
    BMJ. 2026;394:e278125.
    >> Share


    Circulation

  5. PIGEYRE M, Gerstein HC
    Cardiovascular Risk Reduction With GLP-1 RA Drugs.
    Circulation. 2026;154:66-73.
    >> Share


    Clin Chem

  6. MORADIAN A, Becker JO, Nierves LA, Lin TT, et al
    Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.
    Clin Chem. 2026 Jul 4:hvag078. doi: 10.1093.
    >> Share


    Diabet Med

  7. WAITE MA, Kozlowska O, Martin C, Krezalek M, et al
    Piloting an immersive virtual reality 3D self-management education experience for adults with type 1 and type 2 diabetes mellitus: A qualitative study.
    Diabet Med. 2026 Jul 8:e70383. doi: 10.1111/dme.70383.
    >> Share

  8. JONES PJ, Najafi B, Davies MJ, Sarkar P, et al
    Effect of recommended footwear fit upon in-shoe pressures in feet with diabetes-An exploratory study.
    Diabet Med. 2026 Jul 7:e70418. doi: 10.1111/dme.70418.
    >> Share

  9. LEAN M, Davies A
    Re: Interpreting the cost-effectiveness of diabetes remission programmes beyond the durability of remission.
    Diabet Med. 2026 Jul 7:e70410. doi: 10.1111/dme.70410.
    >> Share

  10. SKUDAR S
    Interpreting the cost-effectiveness of diabetes remission programmes beyond the durability of remission.
    Diabet Med. 2026 Jul 7:e70393. doi: 10.1111/dme.70393.
    >> Share


    Diabetes

  11. PRASAD AV, Mathai TS, Balamuralikrishna PTS, Batheja V, et al
    Utility of Pancreatic Perivascular Adipose Tissue as a CT Imaging Biomarker for Diagnosing Type 2 Diabetes.
    Diabetes. 2026 Jul 9:db251140. doi: 10.2337/db25-1140.
    >> Share


    Diabetes Care

  12. VALGAERTS L, De Meulemeester J, Visser MM, Charleer S, et al
    The Correlation Between Fear and Perceived Frequency of Hypoglycemia and Continuous Glucose Monitoring Metrics in Adults With Type 1 Diabetes Using Diabetes Technology: A One-Year Analysis.
    Diabetes Care. 2026 Jul 6:dc260763. doi: 10.2337/dc26-0763.
    >> Share

  13. PYATAK EA, Schneider S, Hernandez R, Hoogendoorn C, et al
    Habituation to Elevated Glucose Levels in Type 1 Diabetes: Function and Well-Being in Guideline-Based Versus Typical Glycemic Range.
    Diabetes Care. 2026 Jul 7:dc260603. doi: 10.2337/dc26-0603.
    >> Share

  14. KHANDAN A, Dehghan Rouzi M, Armstrong DG, Najafi B, et al
    Predicting the Path to Attrition: Multidomain Risk Assessment in Diabetic Foot Ulcer Offloading Randomized Controlled Trials.
    Diabetes Care. 2026 Jul 7:dc260658. doi: 10.2337/dc26-0658.
    >> Share

  15. THELIN MA, Cho S, Callebaut A, Nguyen H, et al
    Type 1 Diabetes Driven by Residual Recipient T Cells After Hematopoietic Cell Transplantation: A Case Report.
    Diabetes Care. 2026 Jul 7:dc260795. doi: 10.2337/dc26-0795.
    >> Share

  16. DREVES B, Joubert M
    Reactive Hypoglycemia as a Transient Metabolic Phenotype of Stage 1 and 2 Type 1 Diabetes.
    Diabetes Care. 2026 Jul 8:dc260921. doi: 10.2337/dc26-0921.
    >> Share

  17. CALLIGARO LI, Liew G, Cho YH, Allen DW, et al
    30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes.
    Diabetes Care. 2026 Jul 8:dc260388. doi: 10.2337/dc26-0388.
    >> Share

  18. ABUABAT MI, Budhram D, Bapat P, Bakhsh A, et al
    Detectable C-Peptide and Diabetic Ketoacidosis Risk in Type 1 Diabetes.
    Diabetes Care. 2026 Jul 9:dc260220. doi: 10.2337/dc26-0220.
    >> Share

  19. GOODMAN IR, Berry SA, McNally EH, Martine-Edith G, et al
    Effects of the Omnipod 5 Hybrid Closed-Loop System in People With Type 1 Diabetes With Impaired Awareness of Hypoglycemia.
    Diabetes Care. 2026 Jul 10:dc260422. doi: 10.2337/dc26-0422.
    >> Share


    Diabetes Obes Metab

  20. ALKABBANI W, Crisafulli S, Paik JM, Tavakkoli A, et al
    Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study.
    Diabetes Obes Metab. 2026;28:7494-7504.
    >> Share

  21. BICKELMANN C, Wilden C, Prates-Roma L, Laschke MW, et al
    Inflammatory Cytokines Impair Glucagon Expression and Secretion in Pancreatic alpha-Cells.
    Diabetes Obes Metab. 2026;28:7149-7160.
    >> Share

  22. HOLLINGHURST J, Augusto M, Tefos F, Bauer R, et al
    Cardiovascular Disease Risk Prediction in Patients With Metabolic Dysfunction-Associated Steatohepatitis.
    Diabetes Obes Metab. 2026;28:7058-7072.
    >> Share

  23. YOKOTE K, Yamauchi T, Fukushima Y, Takatsuka Y, et al
    Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 SYNCHRONIZE-JP Trial.
    Diabetes Obes Metab. 2026;28:6595-6606.
    >> Share

  24. DE FANO M, Haurum LL, Schwarz CR, Porcellati F, et al
    GIP in Cardiovascular and Kidney Disease: From Physiology to Pharmacology.
    Diabetes Obes Metab. 2026;28:6509-6532.
    >> Share

  25. TALAY L, Hom J, Tan M, Ahuja N, et al
    Real-World Effectiveness and 12-Month Persistence of a Semaglutide-Supported Digital Weight-Loss Service: A Retrospective Cohort Study in Germany.
    Diabetes Obes Metab. 2026;28:6985-6996.
    >> Share

  26. COELHO AI, Vale C, Leite AR, Borges-Canha M, et al
    The Potential Role of SGLT2 Inhibitors in Cushing's Disease.
    Diabetes Obes Metab. 2026;28:6550-6560.
    >> Share

  27. HSIEH WC, Henry BM, Edes I
    The Effects of Combined Antihypertensive and Antidiabetic Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
    Diabetes Obes Metab. 2026;28:6874-6887.
    >> Share

  28. HUSSAIN T, Al Faysal J, Kotecha P, Ramon R, et al
    Association of GLP-1 Receptor Agonist Use With Safety Outcomes in Individuals With Opioid Use Disorder: A Target Trial Emulation.
    Diabetes Obes Metab. 2026;28:6861-6873.
    >> Share

  29. CHAN TH, Cosler LE, Gionfriddo MR, Leppien EE, et al
    Association Between Glucagon-Like Peptide-1 Receptor Agonists and Suicidality: A Systematic Review.
    Diabetes Obes Metab. 2026;28:6482-6508.
    >> Share

  30. SU S, Zhou S, Zhou T, Li J, et al
    Long-Term Glycemic Exposure, Control Status and Cognitive Function in Older Adults: A Longitudinal Study.
    Diabetes Obes Metab. 2026;28:6744-6754.
    >> Share

  31. KIM YJ, Cho YK, Kim MS, Lee J, et al
    Association Between SGLT2 Inhibitors and DPP-4 Inhibitors Use and Risk of Acute Pancreatitis: Findings From Nationwide Case-Based Analyses.
    Diabetes Obes Metab. 2026;28:6767-6775.
    >> Share

  32. SILVA CFXCA, de Souza BL, Thomazini G, Junior J, et al
    GLP-1 Receptor Agonists and Psychiatric Outcomes in Adolescents: A Systematic Review and Meta-Analysis.
    Diabetes Obes Metab. 2026;28:6735-6743.
    >> Share

  33. KAZE AD, Juraschek SP, Cohen JB, Singh S, et al
    Prediabetes, Malignant Ventricular Hypertrophy and Stroke: The SPRINT Trial.
    Diabetes Obes Metab. 2026;28:6725-6734.
    >> Share

  34. HEISEY HD, Gregg LP, Verrico CD, Villareal DT, et al
    Rates of, Reasons for, and Reactions to Discontinuation of GLP-1 Receptor Agonists: A Narrative Review.
    Diabetes Obes Metab. 2026;28:6533-6549.
    >> Share

  35. KAKKAR AK, Payra S, Charaya A
    Optic Ischaemic Neuropathy in Incretin-Based Therapy: A Comparative Analysis of Real-World Safety Data.
    Diabetes Obes Metab. 2026;28:7527-7535.
    >> Share

  36. KOSTEV K, Sievert H, Konrad M, Sarabhai T, et al
    Epidemiological Studies on Type 2 Diabetes Using the German Disease Analyser Database: A Narrative Review.
    Diabetes Obes Metab. 2026 Jul 6. doi: 10.1111/dom.71089.
    >> Share

  37. BERRY SA, Goodman IR, McNally E, Elliott J, et al
    Real-World Effectiveness and Safety of Tirzepatide in Type 1 Diabetes and Obesity: Impact on Glycaemia, Weight, and Cardiometabolic Risk Markers.
    Diabetes Obes Metab. 2026 Jul 6. doi: 10.1111/dom.71080.
    >> Share

  38. LEI M, Lin Q, Zhou Y, Ni Y, et al
    Efficacy and Safety of Tubeless Hybrid Closed-Loop Systems in Type 1 Diabetes: A Meta-Analysis of Randomized Controlled Trials.
    Diabetes Obes Metab. 2026 Jul 6. doi: 10.1111/dom.71061.
    >> Share

  39. KAMRUL-HASAN ABM, Chatterjee S, Ashraf H, Nagendra L, et al
    Efficacy and Safety of the Dual Glucagon-Like Peptide-1 and Glucagon Receptor Agonist Mazdutide in Predominantly Chinese Adults With Obesity and/or Type 2 Diabetes: A Systematic Review and Meta-Analysis.
    Diabetes Obes Metab. 2026 Jul 6. doi: 10.1111/dom.71058.
    >> Share

  40. LI D, Ouyang L, Chen Z, Long Y, et al
    Efficacy and Safety of Ion Channel Modulators in Painful Diabetic Neuropathy.
    Diabetes Obes Metab. 2026 Jul 8. doi: 10.1111/dom.71053.
    >> Share

  41. CHEN RT, Nelson AJ, Zoungas S, Clark RA, et al
    Baseline Computed Tomography Coronary Angiography and Polygenic Risk Profiles in Adults With Type 2 Diabetes: A Cross-Sectional Analysis From the VOLTAIRE Study.
    Diabetes Obes Metab. 2026 Jul 8. doi: 10.1111/dom.71072.
    >> Share

  42. ANSON M, Iqbal A, Azmi S, Weston P, et al
    Early Worsening of Diabetic Retinopathy Following Initiation of Hybrid Closed-Loop/Automated Insulin Delivery Systems in Type 1 Diabetes: A Systematic Review and Structured Study-Level Synthesis.
    Diabetes Obes Metab. 2026 Jul 8. doi: 10.1111/dom.71084.
    >> Share

  43. OLIVER N, Gehr B, Lal R, van Dijk PR, et al
    Continuous Intraperitoneal Insulin Infusion for People With Type 1 Diabetes: A Literature Review and International Position Statement.
    Diabetes Obes Metab. 2026 Jul 9. doi: 10.1111/dom.71054.
    >> Share


    Invest Ophthalmol Vis Sci

  44. ZONG Y, Fan Q, Qiu S, Zhang H, et al
    The Molecular Basis of Ocular Aging: Mechanisms, Pathologies, and Emerging Therapeutics.
    Invest Ophthalmol Vis Sci. 2026;67:13.
    >> Share

  45. LI N, Liu L, Sun W, Liu D, et al
    Whole-Exome Analysis Identifies Candidate Genes Associated With Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:25.
    >> Share


    J Diabetes Complications

  46. EDENS MA, Rosien L, van Dijk PR, Bilo H, et al
    Survival and healthcare reimbursements of individuals with lower extremity amputation performed in hospitals with and without a multidisciplinary diabetic foot team: A nationwide study using Dutch reimbursement data (DUDE 12).
    J Diabetes Complications. 2026;40:109363.
    >> Share

  47. SONMEZ A, Haymana C, Demirci I, Cetinarslan B, et al
    Turkish cross-sectional survEy of glycemic and other Metabolic parameters in patients with type 2 Diabetes in 2023: Comparison with 2018 nationwide data (TEMD-2 study).
    J Diabetes Complications. 2026;40:109348.
    >> Share


    J Exp Med

  48. NABI R, Lin CW, Wang Y, Ciecko AE, et al
    Both soluble and cell surface CD137 expressed by Foxp3+ CD4 T cells restrain autoimmune diabetes.
    J Exp Med. 2026;223:e20252647.
    >> Share


    J Nutr

  49. CLISTER D, Chandra QM, Tan MW, Gunawan MC, et al
    Microbiome-Based Precision Interventions in Type 2 Diabetes Mellitus: Mechanisms, Modulators, and Translational Opportunities.
    J Nutr. 2026;156:101596.
    >> Share


    PLoS Med

  50. MANYARA AM, Abdullah S, Balshaf A, Manyanga T, et al
    Hypertension and diabetes prevalence, associated factors, care cascade, and quality of life in older adults: A cross-sectional population-based study in The Gambia, South Africa, and Zimbabwe.
    PLoS Med. 2026;23:e1004785.
    >> Share


    PLoS One

  51. SONG L, Zhou L, Li W
    Molecular mechanisms of autophagy disorder in diabetic neuropathy: Focusing on signaling pathways and regulation of lipid metabolism.
    PLoS One. 2026;21:e0344082.
    >> Share

  52. KIM S, Sang H, Park J, Woo S, et al
    Machine learning for predicting emergency department visits in patients with type 2 diabetes: A real-world, multi-institutional study.
    PLoS One. 2026;21:e0352342.
    >> Share

  53. KUSUMAWATI N, Pijl H, Alaofe H, Yani E, et al
    Knowledge, attitudes, and practices regarding type 2 diabetes and associated factors among rural adolescents in Indonesia: A cross-sectional study.
    PLoS One. 2026;21:e0352982.
    >> Share

  54. CROMER SJ, Gervis JE, Burnett-Bowie SM, Patel CJ, et al
    Heterogeneous associations of socioeconomic status with metabolic disease in racial and ethnic subgroups in the United States: A cross-sectional cohort study in NHANES and All Of Us.
    PLoS One. 2026;21:e0351075.
    >> Share

  55. ZHU G, Zou K, Liang Y, Xie L, et al
    Discovery of hub genes linking oxidative stress to type 2 diabetic sarcopenia using single-cell sequencing and machine learning.
    PLoS One. 2026;21:e0352753.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016